by ODWAdmin | Sep 30, 2025
This study from researchers at the University of Arizona utilized Next-Generation Lipidomics from Panome Bio as part of a larger, multi-omic study to find that hypoxia promotes ferroptosis resistance in prostate cancer by altering lipid metabolism at the...
by Jason Heaviland | Sep 25, 2025 | Uncategorized
The contemporary natural products market demands sophisticated analytical strategies that extend beyond traditional compound identification to encompass comprehensive competitive intelligence and systematic benchmarking methodologies. Modern pharmaceutical and...
by Jason Heaviland | Sep 25, 2025 | Uncategorized
Why PRMT5 Clinical Trials Need Comprehensive Metabolomic Monitoring Current PRMT5 clinical trials are flying with incomplete instruments. While symmetric dimethylarginine (SDMA) has become the standard pharmacodynamic biomarker for monitoring PRMT5 inhibition, relying...
by Jason Heaviland | Sep 24, 2025 | Uncategorized
The Lipid Connection in Neurodegeneration While much of Alzheimer’s disease research has historically focused on protein aggregation (amyloid-beta plaques and tau tangles), a growing body of evidence points to fundamental disruptions in lipid metabolism as both...
by ODWAdmin | Sep 23, 2025
Microbiome Function Through the Lens of Metabolomics This webinar, featuring Dr. Andrew Patterson of Penn State University, will explore how metabolomics is advancing our understanding of host–microbiome interactions, with a special focus on bile acids. Traditionally...
